CA2548740A1 - Treatment of viral infections - Google Patents

Treatment of viral infections Download PDF

Info

Publication number
CA2548740A1
CA2548740A1 CA002548740A CA2548740A CA2548740A1 CA 2548740 A1 CA2548740 A1 CA 2548740A1 CA 002548740 A CA002548740 A CA 002548740A CA 2548740 A CA2548740 A CA 2548740A CA 2548740 A1 CA2548740 A1 CA 2548740A1
Authority
CA
Canada
Prior art keywords
seq
polypeptide
gin
derivative
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002548740A
Other languages
English (en)
French (fr)
Inventor
Curtis Dobson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ai2 Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2548740A1 publication Critical patent/CA2548740A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002548740A 2003-12-24 2004-12-20 Treatment of viral infections Abandoned CA2548740A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0329958.3A GB0329958D0 (en) 2003-12-24 2003-12-24 Treatment of viral infections
GB0329958.3 2003-12-24
PCT/GB2004/005438 WO2005061539A2 (en) 2003-12-24 2004-12-20 Treatment of viral infections

Publications (1)

Publication Number Publication Date
CA2548740A1 true CA2548740A1 (en) 2005-07-07

Family

ID=30776474

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002548740A Abandoned CA2548740A1 (en) 2003-12-24 2004-12-20 Treatment of viral infections

Country Status (6)

Country Link
US (1) US8017579B2 (enExample)
EP (1) EP1711526B1 (enExample)
JP (1) JP2007536910A (enExample)
CA (1) CA2548740A1 (enExample)
GB (1) GB0329958D0 (enExample)
WO (1) WO2005061539A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781219B2 (en) 2003-12-05 2010-08-24 The Cleveland Clinic Foundation Risk markers for cardiovascular disease
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
US7378396B2 (en) 2004-08-11 2008-05-27 The Cleveland Clinic Foundation Therapeutic agents and methods for cardiovascular disease
CN101065479A (zh) 2004-10-15 2007-10-31 蒙奈尔化学感觉中心 培养哺乳动物味细胞的方法
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
AU2006291990B2 (en) 2005-09-13 2012-05-31 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
CA2776513C (en) 2009-11-24 2017-08-01 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
US9234026B2 (en) 2011-07-21 2016-01-12 University of Pittsburgh—of the Commonwealth System of Higher Education Apolipoprotein E polypeptides and their use
MX2014010164A (es) 2012-02-22 2014-11-25 Alethia Biotherapeutics Inc Co-uso de un inhibidor de clusterina con un inhibidor de egfr para tratar cancer.
MY151307A (en) * 2012-06-18 2014-05-05 Univ Malaya Peptides having antimicrobial activity
CN117547596A (zh) * 2023-11-20 2024-02-13 吉林越洋血浆蛋白研究院有限责任公司 人血载脂蛋白a1制品在制备抗包膜病毒药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340727A (en) 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
GB9620153D0 (en) * 1996-09-27 1996-11-13 Univ Strathclyde Non-naturally occurring lipoprotein particle
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
ATE349225T1 (de) 1997-11-06 2007-01-15 Innogenetics Nv Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
AU760794B2 (en) * 1998-03-10 2003-05-22 Regents Of The University Of California, The Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan binding
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US20040014955A1 (en) 2001-12-17 2004-01-22 Carlos Zamudio Identification of essential genes of cryptococcus neoformans and methods of use
US20050208078A1 (en) * 2003-11-20 2005-09-22 Hoffman Stephen L Methods for the prevention of malaria
AU2004283078A1 (en) 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections

Also Published As

Publication number Publication date
WO2005061539A2 (en) 2005-07-07
EP1711526A2 (en) 2006-10-18
WO2005061539A3 (en) 2005-11-24
EP1711526B1 (en) 2012-09-12
US8017579B2 (en) 2011-09-13
GB0329958D0 (en) 2004-01-28
US20090048171A1 (en) 2009-02-19
JP2007536910A (ja) 2007-12-20

Similar Documents

Publication Publication Date Title
US20130150288A1 (en) Treatment of viral infections
CN114736272B (zh) 一种优化病毒膜融合抑制剂的方法及广谱抗冠状病毒脂肽和应用
US20120108520A1 (en) Antimicrobial Compounds and Formulations
US7718610B2 (en) Retrocyclins: antiviral and antimicrobial peptides
US8017579B2 (en) Treatment of viral infections
AU2001237616A1 (en) Antimicrobial compounds and formulations
CN110248953A (zh) 新型订书肽及其用途
EP1272510B1 (en) Pharmacologically active antiviral peptides and methods of their use
WO2009155789A1 (zh) 抑制hiv感染的多肽及其衍生物
CN110128510A (zh) MERS-CoV融合抑制剂
HK1151185A (en) Treatment of viral infections apo e
EP1389126A1 (en) Retrocyclins: antiviral and antimicrobial peptides
KR100438415B1 (ko) 헬리코박터 파일로리 유래의 신규한 항바이러스 펩타이드및 그의 용도
US20200071357A1 (en) Antimicrobial peptides
Woo et al. Characterization of Rhodamine Conjugated Agiotensin II Peptide: Synthesis, Analysis and Receptor Binding and Internalization.
AU2006202024A1 (en) Pharmacologically active antiviral peptides and methods of their use

Legal Events

Date Code Title Description
FZDE Dead